SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001144204-16-123756
Filing Date
2016-09-13
Accepted
2016-09-13 17:13:20
Documents
1
Effectiveness Date
2016-09-13

Document Format Files

Seq Description Document Type Size
1 S-8 POS v448767_s8pos.htm S-8 POS 23929
  Complete submission text file 0001144204-16-123756.txt   24935
Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7
Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770
Transition Therapeutics Inc. (Filer) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: S-8 POS | Act: 33 | File No.: 333-157279 | Film No.: 161883446
SIC: 2833 Medicinal Chemicals & Botanical Products